A Study in Healthy Men to Test How Different Doses of BI 1595043 Are Tolerated

NCT04439838 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: BI 1595043
DRUG: Placebo

Sponsor

Boehringer Ingelheim